What is the latest news on BGXX?

Quantisnow has not tracked any new filings, ratings or press releases for BGXX in the last 30 days. The most recent wire item was published on January 8, 2026.

Where does BGXX stock trade?

Bright Green Corporation (BGXX) is listed on NASDAQ.

What sector and industry is BGXX in?

Bright Green Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.

What companies are similar to BGXX?

Notable peers in the same industry include PRDS (Pardes Biosciences Inc.), SQZ (SQZ Biotechnologies Company), VLON (Vallon Pharmaceuticals Inc.), MNMD (Mind Medicine (MindMed) Inc.), GRPH (Graphite Bio Inc.). Compare BGXX side-by-side with any of them on Quantisnow.

How can I track BGXX on Quantisnow?

Quantisnow aggregates Bright Green Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BGXX to receive live email and push alerts on every new disclosure.

BGXX

NASDAQ

Bright Green Corporation

SectorHealth Care Industry Medicinal Chemicals and Botanical Products

Follow + get alerts

Bright Green Corporation (BGXX) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. There were no new wire items for BGXX in the last 30 days. The most recent was published Jan 8, 2026.

Latest news

25 items

299dPR
Lynn Stockwell and Bright Green Corporation File $3 Billion Lawsuit Against Rodey Law Firm and Attorneys' Liability Assurance Society (ALAS) for Legal Malpractice and Bad Faith
Court Found No Wrongdoing by Lynn Stockwell; Judgment Imposed Joint and Several Liability Due to Counsel's Failure Cibola County, New Mexico, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXXQ) and its Chief Executive Officer, Lynn Stockwell, today announced the filing of a landmark lawsuit seeking damages in excess of $3 billion against Rodey Law Firm and Attorneys' Liability Assurance Society (ALAS). The complaint, filed in the Thirteenth Judicial District Court of New Mexico, alleges legal malpractice, breach of contract, and bad faith breach of fiduciary duty. The underlying litigation resulted in findings of no wrongdoing by Lynn Stockwell. Despite this, the court
413dPR
PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation "BGXXQ" Q and A
Fort Lauderdale, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- PharmAGRI Capital Partners today announced its strategic focus on capturing a $10 billion total addressable market (TAM) in federal procurement of plant-based prescription drugs currently sourced from foreign manufacturers. This segment, while modest in size compared to the broader pharmaceutical industry, represents a critical opportunity to restore control, compliance, and domestic production with a fair transparent pricing model. CEO Statement: "The $10B TAM is not about volume—it's about control. Federal agencies already procure these drugs, often from foreign sources. Our goal is to ensure they contract with a sovereign platfor
414dPR
Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Tesla Robotics to Power Sovereign "Seed to Syringe" Pharmaceutical Infrastructure Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty. The transaction consolidates BGXX's DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico. Effective immediately, Lynn Stockwell has been appointed Chief Executive Officer and Chairwoman of PharmAGRI. Ms. Stockwell wi
592dSEC
SEC Form 25-NSE filed by Bright Green Corporation
25-NSE - Bright Green Corp (0001886799) (Subject)
592dSEC
Bright Green Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Bright Green Corp (0001886799) (Filer)
592dPR
Bright Green Corporation Announces the next steps for the completion of its restructuring plan
FORT LAUDERDALE, FLORIDA, March 21, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on March 17, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the "RSA" Restructuring Security Agreement, Disclosure Statement and Plan. The highlights of the Plan and Disclosure will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution. Lynn Stockwell, the new Chief Executive Officer and Chairman of the Board of Directors of Bright Green Corporation, is also the
614dSEC
Bright Green Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits
8-K - Bright Green Corp (0001886799) (Filer)
617dPR
Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the "RSA" Restructuring Security Agreement. The highlights of the RSA will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution. The Company in its restructuring efforts has entered into an agreement with the DEA to immediately withdraw all Cannabis related renewal applications. This agreement will a
645dSEC
Bright Green Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits
8-K - Bright Green Corp (0001886799) (Filer)
645dPR
Bright Green Corporation Has Signed Agreement with Majority Shareholder as Plan Sponsor on Prepackaged Plan to Restructure the Company.
The Company plans to emerge with federal loan guarantees for its 60 new mega farm owner/operators, that collectively will invest $3.5 billion to supply and strengthen the Drugs Made in America supply Chain. FORT LAUDERDALE, FLORIDA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced that on January 21, 2025, it has entered into a Restructuring Support Agreement (the "RSA") with Lynn Stockwell, a major shareholder of the Company (the "Plan Sponsor") to restructure the Company. To implement the terms of the RSA, the Company will file, and the Plan Sponsor will support the Company's Prepackaged Plan of Reorganization Under Chapte
676dSEC
Bright Green Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Bright Green Corp (0001886799) (Filer)
676dPR
LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT ("RSA") WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.
GRANTS, NEW MEXICO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) ("Bright Green" or the "Company") announced today that Lynn Stockwell has agreed to terms for a restructuring security agreement ("RSA") with Bright Green that is expected to be executed soon.Lynn Stockwell, the founder of Bright Green Corporation, Drugs Made in America Acquisition Corp I, and Drugs Made in America Acquisition Corp II seeks to align her vision to on-shore the end-to-end active pharmaceutical ingredient ("API") manufacturing back to the United States. The plan realigns the Company with her plan to scale and position the Company as the facilitator and supplier of plant-based controlled
714dSEC
SEC Form 10-Q filed by Bright Green Corporation
10-Q - Bright Green Corp (0001886799) (Filer)
715dSEC
Bright Green Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Bright Green Corp (0001886799) (Filer)
719dSEC
SEC Form NT 10-Q filed by Bright Green Corporation
NT 10-Q - Bright Green Corp (0001886799) (Filer)
746dSEC
SEC Form DEF 14A filed by Bright Green Corporation
DEF 14A - Bright Green Corp (0001886799) (Filer)
760dSEC
SEC Form PRER14A filed by Bright Green Corporation
PRER14A - Bright Green Corp (0001886799) (Filer)
775dPR
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or the "Company"), today announced that trading of its shares have been suspended from the Nasdaq Stock Exchange ("Nasdaq") after Nasdaq cancelled the scheduled September 26, 2024 delist appeal hearing. While this development represents a change in the Company's public trading status, Bright Green remains committed to pursuing its strategic goals and delivering value to its shareholders. The Company filed its Proxy Statement and will proceed with its scheduled annual meeting on November 15, 2024, during which shareholders will discuss key issues, including the potential for a reve
776dSEC
Bright Green Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Bright Green Corp (0001886799) (Filer)
776dSEC
SEC Form PRE 14A filed by Bright Green Corporation
PRE 14A - Bright Green Corp (0001886799) (Filer)
783dINSIDER
Chief Financial Officer Elmasri Saleem sold $4,951 worth of shares (25,942 units at $0.19), decreasing direct ownership by 2% to 1,103,476 units (SEC Form 4)
4 - Bright Green Corp (0001886799) (Issuer)
784dINSIDER
Chief Financial Officer Elmasri Saleem sold $14,313 worth of shares (71,809 units at $0.20), decreasing direct ownership by 6% to 1,129,418 units (SEC Form 4)
4 - Bright Green Corp (0001886799) (Issuer)
785dSEC
SEC Form 144 filed by Bright Green Corporation
144 - Bright Green Corp (0001886799) (Subject)
785dINSIDER
Amendment: Chief Executive Officer Singh Gurvinder was granted 5,500,000 shares (SEC Form 4)
4/A - Bright Green Corp (0001886799) (Issuer)
785dINSIDER
Amendment: Director Deson Sean was granted 238,209 shares (SEC Form 4)
4/A - Bright Green Corp (0001886799) (Issuer)

BGXX FAQ

5 questions

What is the latest news on BGXX?
Quantisnow has not tracked any new filings, ratings or press releases for BGXX in the last 30 days. The most recent wire item was published on January 8, 2026.
Where does BGXX stock trade?
Bright Green Corporation (BGXX) is listed on NASDAQ.
What sector and industry is BGXX in?
Bright Green Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.
What companies are similar to BGXX?
Notable peers in the same industry include PRDS (Pardes Biosciences Inc.), SQZ (SQZ Biotechnologies Company), VLON (Vallon Pharmaceuticals Inc.), MNMD (Mind Medicine (MindMed) Inc.), GRPH (Graphite Bio Inc.). Compare BGXX side-by-side with any of them on Quantisnow.
How can I track BGXX on Quantisnow?
Quantisnow aggregates Bright Green Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BGXX to receive live email and push alerts on every new disclosure.